Indo US Bio-Tech Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is -26.09% vs 0.26% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -13.04% vs -26.60% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -0.48% vs -23.77% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 83.33% vs -6.67% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Indo US Bio-Tech With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

22.80

65.96

-43.16

-65.43%

Other Operating Income

0.00

Total Operating income

22.80

65.96

-43.16

-65.43%

Raw Material Cost

0.00

Purchase of Finished goods

20.34

1.02

19.32

1,894.12%

(Increase) / Decrease In Stocks

-19.96

-73.12

53.16

72.70%

Employee Cost

0.33

11.14

-10.81

-97.04%

Power Cost

0.00

Manufacturing Expenses

15.60

101.20

-85.60

-84.58%

Selling and Distribution Expenses

0.00

7.14

-7.14

-100.00%

Other Expenses

2.34

9.74

-7.40

-75.98%

Total Expenditure (Excl Depreciation)

18.65

57.12

-38.47

-67.35%

Operating Profit (PBDIT) excl Other Income

4.15

8.84

-4.69

-53.05%

Other Income

0.01

1.74

-1.73

-99.43%

Operating Profit (PBDIT)

4.16

10.58

-6.42

-60.68%

Interest

0.77

4.18

-3.41

-81.58%

Exceptional Items

0.00

2.69

-2.69

-100.00%

Gross Profit (PBDT)

3.39

9.09

-5.70

-62.71%

Depreciation

0.22

0.98

-0.76

-77.55%

Profit Before Tax

3.16

8.10

-4.94

-60.99%

Tax

0.17

0.87

-0.70

-80.46%

Provisions and contingencies

0.00

Profit After Tax

3.00

7.23

-4.23

-58.51%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

3.00

7.23

-4.23

-58.51%

Equity Capital

20.05

19.00

1.05

5.53%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.50

3.81

-2.31

-60.63%

Diluted Earnings per share

1.49

3.80

-2.31

-60.79%

Operating Profit Margin (Excl OI)

18.20%

13.40%

0.00

4.80%

Gross Profit Margin

14.87%

13.78%

0.00

1.09%

PAT Margin

13.16%

10.96%

0.00

2.20%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 22.80 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -26.09% vs 0.26% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -3.23% vs 6.56% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 3.00 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -13.04% vs -26.60% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -40.59% vs 37.23% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 4.15 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -0.48% vs -23.77% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -25.09% vs 30.66% in Dec 2024

Quarterly - Interest

Interest 0.77 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 83.33% vs -6.67% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 102.63% vs 2.70% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 18.20%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024